Search research articles
Contact Us
Filters
Showing results (31-40 of 152) with videos related to
Page
of 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2018
Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
Robin Bacher, Melanie Hohberg, Markus Dietlein, et al.
Molecular Imaging and Biology
|
February 28, 2016
Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [(177)Lu]DKFZ-PSMA-617
Melanie Hohberg, Wolfgang Eschner, Matthias Schmidt, et al.
Journal of Thoracic Disease
|
January 22, 2016
Developments in oncological positron emission tomography/computed tomography assessment
Carsten Kobe, Ronald Boellaard, Jürgen Wolf, et al.
Onkologie
|
February 13, 2008
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma
Roland Schnell, Markus Dietlein, Klaus Schomäcker, et al.
Diagnostics (Basel, Switzerland)
|
February 25, 2022
Influences on PET Quantification and Interpretation
Julian M M Rogasch, Frank Hofheinz, Lutz van Heek, et al.
The Cochrane Database of Systematic Reviews
|
March 26, 2025
Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphoma
Nina Kreuzberger, Marius Goldkuhle, Bastian von Tresckow, et al.
Nuclear Medicine Communications
|
November 13, 2009
Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
Carsten Kobe, Wolfgang Eschner, Markus Wild, et al.
Nuklearmedizin. Nuclear Medicine
|
March 28, 2009
[Should all patients with thyroid nodules > or = 1 cm undergo fine-needle aspiration biopsy?]
Harald Schicha, M Hellmich, W Lehmacher, et al.
Expert Review of Anticancer Therapy
|
September 15, 2010
The role of PET in Hodgkin's lymphoma and its impact on radiation oncology
Carsten Kobe, Markus Dietlein, Jan Kriz, et al.
Hemasphere
|
June 23, 2022
Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD
Nadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 152) with videos related to
Sort By:
Page
of 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 14, 2018
Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
Robin Bacher, Melanie Hohberg, Markus Dietlein, et al.
Molecular Imaging and Biology
|
February 28, 2016
Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [(177)Lu]DKFZ-PSMA-617
Melanie Hohberg, Wolfgang Eschner, Matthias Schmidt, et al.
Journal of Thoracic Disease
|
January 22, 2016
Developments in oncological positron emission tomography/computed tomography assessment
Carsten Kobe, Ronald Boellaard, Jürgen Wolf, et al.
Onkologie
|
February 13, 2008
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma
Roland Schnell, Markus Dietlein, Klaus Schomäcker, et al.
Diagnostics (Basel, Switzerland)
|
February 25, 2022
Influences on PET Quantification and Interpretation
Julian M M Rogasch, Frank Hofheinz, Lutz van Heek, et al.
The Cochrane Database of Systematic Reviews
|
March 26, 2025
Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphoma
Nina Kreuzberger, Marius Goldkuhle, Bastian von Tresckow, et al.
Nuclear Medicine Communications
|
November 13, 2009
Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
Carsten Kobe, Wolfgang Eschner, Markus Wild, et al.
Nuklearmedizin. Nuclear Medicine
|
March 28, 2009
[Should all patients with thyroid nodules > or = 1 cm undergo fine-needle aspiration biopsy?]
Harald Schicha, M Hellmich, W Lehmacher, et al.
Expert Review of Anticancer Therapy
|
September 15, 2010
The role of PET in Hodgkin's lymphoma and its impact on radiation oncology
Carsten Kobe, Markus Dietlein, Jan Kriz, et al.
Hemasphere
|
June 23, 2022
Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD
Nadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin, et al.
Page
of 16